Efficacy and safety of different Janus kinase inhibitors combined with methotrexate for the treatment of rheumatoid arthritis: a single-center randomized trial

Abstract Objective To compare the efficacy and safety between baricitinib (BARI) and tofacitinib (TOFA) for the treatment of the rheumatoid arthritis (RA) patients receiving methotrexate (MTX) in clinical practice. Methods This retrospective study recruited 179 RA patients treated with BARI (2–4 mg/...

Full description

Bibliographic Details
Published in:Advances in Rheumatology
Main Authors: Xiaoling Liao, Wang Huo, Wen Zeng, Fang Qin, Fei Dong, Wanling Wei, Ling Lei
Format: Article
Language:English
Published: BMC 2023-10-01
Subjects:
Rheumatoid arthritis
Baricitinib
Tofacitinib
Janus kinase (JAK) inhibitors
Disease Activity Scale-28 (DAS-28)
Online Access:https://doi.org/10.1186/s42358-023-00331-1

Internet

https://doi.org/10.1186/s42358-023-00331-1

Similar Items